Tata India Pharma Healthcare Fund Regular Plan Growth | Pros & Cons NAV(15.76)

Tata India Pharma Healthcare Fund Regular Plan Growth

Fund Information

Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Very High Risk

Nifty Pharma

Benchmark

2015-12-28

Launched On

Type

150

Min SIP

5000

Min Investment

558

AUM in Crores

2.57

Expense Ratio

0.25

Exit Load

Tata Asset Management Limited

Fund House

Meeta Shetty

Fund Managers

Tata India Pharma Healthcare Fund Regular Plan Pros & Cons

Pros

  • Tata India Pharma Healthcare Fund Regular Plan Growth has over performed index in 2015-2018, 2016-2019, 2017-2020 years
  • 3 years avg returns are higher than benchmark
  • Tata India Pharma Healthcare Fund Regular Plan Growth is ranking 4th in last 5 years

Cons

  • Higher Expense Ratio

Average Returns

Fund Name1Y (%)3Y (%)5Y (%)7Y (%)10Y (%)15Y (%)
Tata India Pharma Healthcare Fund Regular Plan Growth 
10.7824.6912.64
Nifty Pharma
6.2416.45.162.3411.2811.83

Tata India Pharma Healthcare Fund Regular Plan Rolling Returns

Fund Name3 Year (%)5 Year (%)
AverageMaxMinAverageMaxMin
Tata India Pharma Healthcare Fund Regular Plan Growth 
12.7235.14-6.5519.7721.815.73
Nifty Pharma
15.4346.82-14.614.7833.55-12.05

Risk Parameters

Fund NameMeanStdSharpeBetaAlpha
Tata India Pharma Healthcare Fund Regular Plan Growth 
27.3417.491.2930.7113.27
Nifty Pharma
17.8923.070.57--
Risk Parameters are calculated for the last 3 years data.

Calender Year Returns

Performance

Best PerformanceWorst Performance
PeriodReturnsPeriodReturns
Week2020-04-01 - 2020-04-08
17.58
2020-03-05 - 2020-03-12
-11.13
Month2020-03-27 - 2020-04-27
31.54
2020-02-19 - 2020-03-19
-17.12
Quarter2020-04-01 - 2020-08-01
41.47
2017-04-21 - 2017-08-21
-15.46
Year2020-03-23 - 2021-03-23
73.72
2016-09-08 - 2017-09-08
-18.7

Portfolio

Stock NameSector% of Total Holdings
Sun Pharmaceutical IndustriesHealthcare12.36
Divi's LaboratoriesHealthcare9.65
Dr. Reddy's LabHealthcare8.64
CiplaHealthcare8.11
Alkem LaboratoriesHealthcare6.67
Apollo HospitalsHealthcare6.44
Ipca LaboratoriesHealthcare6.1
Narayana HrudayalayaHealthcare5.19
LupinHealthcare3.69
Fortis HealthcareHealthcare3.48
JB Chemicals & PharmaHealthcare3.1
Procter & Gamble HealthHealthcare2.53
Krishna Institute Of Medical SciencesHealthcare2.34
FDCHealthcare2.16
Gland PharmaHealthcare2.03
Syngene InternationalHealthcare1.94
Abbott IndiaHealthcare1.83
Indoco RemediesHealthcare1.83
Healthcare Global EnterprisesHealthcare1.66
Ajanta PharmaHealthcare1.62
Glenmark Pharma.Healthcare1.51
Aurobindo PharmaHealthcare1.3
Sanofi IndiaHealthcare0.82
Glaxosmithkline PharmaHealthcare0.8
Dr. Lal PathlabsHealthcare0.8

AUM Yearly

YearScheme Total AumCategory Total Aum
2021533.610.00
2020419.330.00
2019166.0869743.22

Tata India Pharma Healthcare Fund Regular Plan Details

Tata India Pharma Healthcare Fund Regular Plan Growth is a mutual fund scheme launched by Tata Asset Management Limited.This fund has been launched on 2015-12-28. Tata India Pharma Healthcare Fund Regular Plan Growth currently has 558 crores of assets under management (AUM) and has an expense ratio of 2.57 which is higher than what most other Large Cap funds charge.


Tata India Pharma Healthcare Fund Regular Plan Growth has given returns of 10.78% in the last 1 year and 24.69% in the last 3 years. And since launch the fund has given 7.22% returns.


This fund invests in companies which are fundamentally strong and having growth potential.


Min sip to invest in this fund is Rs.150 and lumpsum investment is Rs.5000.

The top holdings of the fund are Sun Pharmaceutical Industries , Divi's Laboratories , Dr. Reddy's Lab , Cipla , Alkem Laboratories

Frquently Asked Questions

1. What is the NAV of Tata India Pharma Healthcare Fund Regular Plan ?

The current Net Asset Value (NAV) of the Tata India Pharma Healthcare Fund Regular Plan is 15.76

2. Tata India Pharma Healthcare Fund Regular Plan Rolling Returns

The 3 year rolling returns of the Tata India Pharma Healthcare Fund Regular Plan :

  • Mean : 12.72%
  • Max : 35.14%
  • Min : -6.55%

3. How do I invest in Tata India Pharma Healthcare Fund Regular Plan ?

  1. Click here Invest Now
  2. Select one Broker platform from the pop up
  3. Invest and enjoy the returns

Tata India Pharma Healthcare Fund Regular Plan Growth



Investment Duration 3 years

Disclaimer

Please note that these calculators are for illustrations only and do not represent actual returns. Mutual Funds do not have a fixed rate of return and it is not possible to predict the rate of return.